STING1 and Carcinoma, Lewis Lung: On the other hand, STING activation has been shown to attenuate tumor cell killing and promote tolerogenic responses during Lewis lung carcinoma (LLC) growth by stimulating local indoleamine 2,3 dioxygenase (IDO) activity and decreasing CD8+ T cell effector functions during tumorigenesis [49].